Trial intelligence / Profile preview

Effect of sitagliptin and glibenclamide on treatment of diabetic patients

IRCT2015102824768N1Phase 2Completed

Sponsor
Ahvaz Jundishapur University of Medical Sciences
Start
Jul 2015
Modality
Small Molecules
Countries
1
01

Overview

Phase 2 trial of sitagliptin and glibenclamide in type 2 diabetes mellitus (T2DM), sponsored by Ahvaz Jundishapur University of Medical Sciences. Started Jul 2015; status: completed.

02

Drugs

sitagliptinglibenclamide
03

Conditions

type 2 diabetes mellitus (T2DM)

Beyond the preview

Go deeper on IRCT2015102824768N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT2015102824768N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call